- Home
- CDT vs LMFA Comparison
CDT vs LMFA Comparison
Compare CDT & LMFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDT
- LMFA
- Stock Information
- Founded
- CDT 2019
- LMFA 2008
- Country
- CDT United States
- LMFA United States
- Employees
- CDT N/A
- LMFA N/A
- Industry
- CDT Biotechnology: Pharmaceutical Preparations
- LMFA Finance: Consumer Services
- Sector
- CDT Health Care
- LMFA Finance
- Exchange
- CDT Nasdaq
- LMFA Nasdaq
- Market Cap
- CDT 11.1M
- LMFA 9.2M
- IPO Year
- CDT N/A
- LMFA 2015
- Fundamental
- Price
- CDT $0.06
- LMFA $1.97
- Analyst Decision
- CDT
- LMFA Hold
- Analyst Count
- CDT 0
- LMFA 1
- Target Price
- CDT N/A
- LMFA N/A
- AVG Volume (30 Days)
- CDT 104.2M
- LMFA 81.8K
- Earning Date
- CDT 02-14-2025
- LMFA 11-13-2024
- Dividend Yield
- CDT N/A
- LMFA N/A
- EPS Growth
- CDT N/A
- LMFA N/A
- EPS
- CDT N/A
- LMFA N/A
- Revenue
- CDT N/A
- LMFA $12,838,084.00
- Revenue This Year
- CDT N/A
- LMFA N/A
- Revenue Next Year
- CDT N/A
- LMFA N/A
- P/E Ratio
- CDT N/A
- LMFA N/A
- Revenue Growth
- CDT N/A
- LMFA 27.81
- 52 Week Low
- CDT $0.05
- LMFA $1.84
- 52 Week High
- CDT $3.92
- LMFA $6.11
- Technical
- Relative Strength Index (RSI)
- CDT 42.52
- LMFA 37.40
- Support Level
- CDT $0.08
- LMFA $1.84
- Resistance Level
- CDT $0.18
- LMFA $2.37
- Average True Range (ATR)
- CDT 0.02
- LMFA 0.19
- MACD
- CDT -0.00
- LMFA 0.00
- Stochastic Oscillator
- CDT 0.41
- LMFA 18.31
About CDT Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by leading biopharmaceutical companies in order to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready in autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
About LMFA LM Funding America Inc.
LM Funding America Inc is a financial services company. The company provides funding to nonprofit community associations located in the state of Florida and to nonprofit community associations in the states of Washington and Colorado. Its products include Original Product and New Neighbor Guaranty. Its original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. It currently has two lines of business recently commenced cryptocurrency mining business and historical specialty finance business. The Company has two operating segments: Specialty Finance and Mining Operations, which generate the majority of its revenue.